The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-11 of 11 articles
Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition
Gragnano F,
Spirito A,
Corpataux N,
Vaisnora L,
Galea R,
Gargiulo G,
Siontis G,
Praz F,
Lanz J,
Billinger M,
Hunziker L,
Stortecky S,
Pilgrim T,
Bär S,
Ueki Y,
Capodanno D,
Urban P,
Pocock S,
Mehran R,
Heg D,
Windecker S,
Räber L,
Valgimigli M
December 3, 2021 | 10.4244/EIJ-D-21-00181
Defining the HBR patient – another step in the right direction
August 28, 2020 | 10.4244/EIJV16I5A64
Polymer-free drug-coated stents: workhorse or “niche horse”?
September 20, 2018 | 10.4244/EIJV14I7A128
Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial
Lipiecki J,
Brunel P,
Morice M,
Roguelov C,
Walsh S,
Richardt G,
Eerdmans P,
Zambahari R,
Berland J,
Copt S,
Stoll H,
Urban P
July 20, 2018 | 10.4244/EIJ-D-18-00293
Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy
Jensen C,
Naber C,
Urban P,
Ong P,
Valdés Chávarri M,
Abizaid A,
Pocock S,
Fabbiocchi F,
Dubois C,
Copt S,
Stoll H,
Morice M
March 20, 2018 | 10.4244/EIJ-D-17-00720
Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial
Filipovic-Pierucci A,
Durand-Zaleski I,
Butel T,
Greene S,
Hovasse T,
Iñiguez A,
Nazzaro M,
Oldroyd K,
Talwar S,
Richardt G,
Windhovel U,
Urban P,
Morice M
February 20, 2018 | 10.4244/EIJ-D-17-00286
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study
Danzi G,
Chevalier B,
Urban P,
Fath-Ordoubadi F,
Carrié D,
Wiemer M,
Serra A,
Wijns W,
Kala P,
Stabile A,
Ruigomez J,
Sagic D,
Laanmets P,
Strupp G,
West N,
Paunovic D
May 15, 2012 | 10.4244/EIJV8I1A17
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry
Cuculi F,
Banning AP,
Abizaid A,
Bartorelli A,
Baux A,
Dzavik V,
Ellis S,
Gao R,
Holmes D,
Jeong M,
Legrand V,
Neumann F,
Nyakern M,
Spaulding C,
Stoll H,
Worthley SG,
Urban P
December 30, 2011 | 10.4244/EIJV7I8A152
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023